Bibliography

Export 27 results:

Filters: Author is Alexander,J. W. [Clear All Filters]

2006

Alexander JW, Goodman HR, Cardi M, Austin J, Goel S, Safdar S, et al. Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation. Transpl Int. 2006;19(4):295-302.

2005

Boardman RE, Alloway RR, Alexander JW, Buell JF, Cardi M, First MR, et al. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant. 2005;5(2):356-65.

Rogers CC, Alloway RR, Buell JF, Boardman R, Alexander JW, Cardi M, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation. 2005;80(1):26-33.

Rogers CC, Hanaway M, Alloway RR, Alexander JW, Boardman RE, Trofe J, et al. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc. 2005;37(2):795-7.

Rogers CC, Alloway RR, Boardman R, Trofe J, Hanaway MJ, Alexander JW, et al. Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation. Transplant Proc. 2005;37(2):812-3.

Woodle ES, Susskind B, Alloway RR, Hanaway MJ, Thomas M, Buell J, et al. Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens. Transplant Proc. 2005;37(2):809-11.

Buell JF, Lee L, Martin JE, Dake NA, Cavanaugh TM, Hanaway MJ, et al. Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study. Clin Transplant. 2005;19(1):102-9.

Woodle ES, Alloway RR, Buell JF, Alexander JW, Munda R, Roy-Chaudhury P, et al. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant. 2005;5(11):2740-4.

Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Hanaway MJ, et al. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.

2002

Buell JF, Hanaway MJ, Potter SR, Cronin DC, Yoshida A, Munda R, et al. Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomy. Am J Transplant. 2002;2(10):983-8.

Alexander JW, Stanley LL, Ofstedal TL, First MR, Cardi MA, Safdar S, et al. Transplantation without steroids. Transplant Proc. 2002;34(6):2076-8.

1992

Alexander JW, Babcock GF, First MR, Davies CB, Madden RL, Munda R, et al. The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial. Transplantation. 1992;53(2):423-7.

1991

Fisher RA, Tchervenkov JI, Schroeder TJ, Alexander JW, Munda R, Penn I, et al. Efficacy of induction therapy in cadaveric renal transplantation comparing rabbit antithymocyte serum and Minnesota antilymphoblast globulin. Transplant Proc. 1991;23(1 Pt 2):1253-5.

Alexander JW, First MR, Hariharan S, Penn I, Schroeder T, Ryckman F, et al. Recent contributions to transplantation at the University of Cincinnati. Clin Transpl. 1991:159-78.

Schroeder TJ, Pesce AJ, Ryckman FC, Tressler TP, Brunson ME, Pedersen SH, et al. Selection criteria for liver transplant donors. J Clin Lab Anal. 1991;5(4):275-7.

Alexander JW, Vaughn WK. The use of "marginal" donors for organ transplantation. The influence of donor age on outcome. Transplantation. 1991;51(1):135-41.

1989

First MR, Smith RD, Weiss MA, Schroeder TJ, Kant KS, Munda R, et al. Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation. Transplant Proc. 1989;21(1 Pt 2):1567-70.

First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, et al. Immune monitoring during retreatment with OKT3. Transplant Proc. 1989;21(1 Pt 2):1753-4.

Schroeder TJ, Gremse DA, Mansour ME, Theuerling AW, Brunson ME, Ryckman FC, et al. Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients. Transplant Proc. 1989;21(1 Pt 2):2299-301.

Hariharan S, First MR, Munda R, Penn I, Schroeder TJ, Fidler J, et al. Prednisone withdrawal in HLA-identical living related donor transplant recipients. Transplant Proc. 1989;21(1 Pt 2):1617-9.

Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients. Am J Kidney Dis. 1989;14(5 Suppl 2):14-8.

First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, et al. Successful retreatment of allograft rejection with OKT3. Transplantation. 1989;47(1):88-91.

1988

Shah B, First MR, Munda R, Penn I, Fidler JP, Alexander JW. Current experience with renal transplantation in older patients. Am J Kidney Dis. 1988;12(6):516-23.

1986

First MR, Alexander JW, Wadhwa N, Penn I, Munda R, Fidler JP, et al. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation. Transplant Proc. 1986;18(2 Suppl 1):132-5.

1984

First MR, Vaidya PN, Maryniak RK, Weiss MA, Munda R, Fidler JP, et al. Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation. 1984;38(6):607-12.

Pages